Adipokines, Inflammation, and Metabolic Diseases
Adipokines, Inflammation, and Metabolic Diseases is a research topic within Epidemiology. Science Explorer counts 48k research works in it since 1950. 9.9% of them reached the world's top 10% most cited for their field and year.
This cluster of papers explores the intricate relationship between inflammation and obesity, focusing on the impact of chronic inflammation in adipose tissue on the development of obesity-related metabolic disorders such as insulin resistance, cardiovascular disease, and type 2 diabetes. The role of adipokines, macrophage accumulation, and C-reactive protein in linking inflammation to metabolic syndrome is also extensively studied.
- Inflammation
- Obesity
- Adipose Tissue
- Insulin Resistance
- Cardiovascular Disease
- Adipokines
- Macrophages
- C-Reactive Protein
- Metabolic Syndrome
- Type 2 Diabetes
- Research works
- 48k fractional, since 1950
- In the world top 10%
- 4.8k per year above
- Top-10% rate
- 9.9% share of its works in the world top 10%
- Growth, 2018-21 → 2022-25
- +6% the tick is no change
- Largest producer
China
40% of the 10 largest, 2022-now
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Adipokines, Inflammation, and Metabolic Diseases research?
By volume, China and the United States publish the most (2.7k and 1.4k works in 2022-now).
By volume, 2022-now
- 1
China 2.7k works
- 2
United States 1.4k works
- 3
India 520 works
- 4
Iran 331 works
- 5
Türkiye 322 works
- 6
South Korea 305 works
- 7
Japan 290 works
- 8
Germany 286 works
- 9
Italy 248 works
- 10
Spain 231 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Adipokines, Inflammation, and Metabolic Diseases research?
By volume in 2022-now, Harvard University publishes the most Adipokines, Inflammation, and Metabolic Diseases research, followed by Shanghai Jiao Tong University and Capital Medical University.
By volume, 2022-now
- 1
Harvard University
United States 73 works
- 2
Shanghai Jiao Tong University
China 68 works
- 3
Capital Medical University
China 67 works
- 4
Chinese Academy of Medical Sciences & Peking Union Medical College
China 65 works
- 5
Russian Academy of Sciences
Russia 58 works
- 6
Nanjing Medical University
China 53 works
- 7
Islamic Azad University, Tehran
Iran 50 works
- 8
Central South University
China 48 works
- 9
Sichuan University
China 47 works
- 10
Sun Yat-sen University
China 46 works
Who are the leading researchers in Adipokines, Inflammation, and Metabolic Diseases?
The most-cited researchers publishing on Adipokines, Inflammation, and Metabolic Diseases include Eric S. Lander, George Davey Smith and Ali H. Mokdad.
- 1
Eric S. Lander
United States 524k citations
- 2
George Davey Smith
United Kingdom 435k citations
- 3
Ali H. Mokdad
United States 429k citations
- 4
Walter Churchill Willett
United States 411k citations
- 5
Stacey L. Gabriel
United States 402k citations
- 6
Robert John Tibshirani
United States 396k citations
- 7
John J.V. McMurray
United Kingdom 349k citations
- 8
Hermann Brenner
Germany 343k citations
- 9
Shizuo Akira
Japan 342k citations
- 10
Cyrus Cooper
United Kingdom 342k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Adipokines, Inflammation, and Metabolic Diseases research done?
The largest centres of Adipokines, Inflammation, and Metabolic Diseases research in 2022-now are Beijing (China), Shanghai (China), Guangzhou (China) and Seoul (South Korea). Among places with at least 20 works in it, it is an unusually large share of all research in Giessen.
Largest cities, 2022-now
Where it is the local speciality
- GiessenDE · 23.1 works6.4×
Location quotient: how much more of its research is in Adipokines, Inflammation, and Metabolic Diseases than the world average.
Where is the best place to study Adipokines, Inflammation, and Metabolic Diseases?
Among universities, judged by research, Harvard University, University of Copenhagen and Chinese Academy of Medical Sciences & Peking Union Medical College score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.
Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.
Every institution in Adipokines, Inflammation, and Metabolic Diseases, country by countryIs Adipokines, Inflammation, and Metabolic Diseases research growing?
Output in 2022-2025 was 6% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Adipokines, Inflammation, and Metabolic Diseases.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Adipokines, Inflammation, and Metabolic Diseases as a percentage of every work published that year, 0.038% in 2024.
Fractional works of Adipokines, Inflammation, and Metabolic Diseases over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year.
Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.
Discussion
Ask a question or share a note about Adipokines, Inflammation, and Metabolic Diseases. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.